David A. Siegel Repare Therapeutics Inc. Transaction History
Two Sigma Advisers, LP
- $46.1 Billion
- Q2 2025
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 27,700 shares of RPTX stock, worth $52,630. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,700Holding current value
$52,630% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding RPTX
# of Institutions
56Shares Held
30.8MCall Options Held
163KPut Options Held
0-
Bvf Inc San Francisco, CA10.3MShares$19.6 Million0.56% of portfolio
-
Blue Owl Capital Holdings LP New York, NY3.44MShares$6.54 Million2.59% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.32MShares$6.31 Million0.16% of portfolio
-
Chi Advisors LLC New York, NY2.97MShares$5.64 Million17.66% of portfolio
-
Versant Venture Management, LLC San Francisco, CA2.65MShares$5.03 Million6.53% of portfolio
About Repare Therapeutics Inc.
- Ticker RPTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,937,800
- Market Cap $79.7M
- Description
- Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...